MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Bombay Pharma Equipments

U33110MH2008PTC189053ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed

Bombay Pharma Equipments is a Private Indian company incorporated in 1927 and based in Maharashtra, India. Bombay Pharma Equipments operates in Medical & Precision (NIC 33110) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
1927
99 years old
State
Maharashtra
Sector
Medical & Precision
NIC 33110
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
Bombay Pharma EquipmentsTRACXN · PUBLIC DATA
Brand Bombay Pharma Equipments · Legal entity Bombay Pharma Equipments

Bombay Pharma Equipments - Manufacturer of filtration systems designed for solid-liquid separation in various industries.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
Unfunded
HQ
Mumbai
Founded
1927
Source: Tracxn (public profile) · joined to MCA on CIN U33110MH2008PTC189053

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
33110
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Medical & Precision
ROC
—
Website
https://sparklerfilterpress.com
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
PN
Priya Nair
Managing Director
2.1y · Ahmedabad · DIN 1205439
RK
Rajesh Kumar Sharma
Director
8.6y · New Delhi · DIN 8084044
Get the full board of directors

Directors, DINs & appointment history for Bombay Pharma Equipments.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 2024+30dfiled
MGT-7FY2024-2520 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2425 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2321 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Bombay Pharma Equipments.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
751575627ICICI Bank Ltd(Bank)₹19.45 Cr27 Jan 2020Satisfied
876502065Kotak Mahindra Bank Ltd(Bank)₹21.16 Cr04 Jul 2021Open
411276677ICICI Bank Ltd(Bank)₹17.66 Cr19 Sep 2022Satisfied
847689214Kotak Mahindra Bank Ltd(Bank)₹12.27 Cr12 Mar 2021Open
229301235Axis Bank Ltd(Bank)₹9.37 Cr12 Mar 2019Satisfied
See registered charges & lenders

Charge IDs, lenders & amounts for Bombay Pharma Equipments.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹4.71 Cr₹57.60 L₹2.62 Cr₹5.38 Cr312
FY2023-24₹3.91 Cr₹43.47 L₹1.30 Cr₹3.63 Cr20
FY2022-23₹3.75 Cr₹54.02 L₹2.93 Cr₹6.33 Cr237
FY2021-22₹3.78 Cr₹45.14 L₹1.97 Cr₹4.48 Cr186
Gain deeper financial insights of this entity

Audited financials & ratios for Bombay Pharma Equipments.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹4.71 Cr₹3.91 Cr₹3.75 Cr₹3.78 Cr
Other income₹8.57 L₹12.30 L₹13.61 L₹13.90 L
Total income₹4.79 Cr₹4.03 Cr₹3.89 Cr₹3.92 Cr
Total expenses₹4.05 Cr₹3.48 Cr₹3.19 Cr₹3.34 Cr
Profit before tax₹74.87 L₹56.51 L₹70.23 L₹58.69 L
Profit / (Loss) after tax₹57.60 L₹43.47 L₹54.02 L₹45.14 L
Balance sheet
Equity / Net worth₹2.62 Cr₹1.30 Cr₹2.93 Cr₹1.97 Cr
Borrowings₹74.63 L₹99.44 L₹1.47 Cr₹54.13 L
Current liabilities₹97.95 L₹1.32 Cr₹1.77 Cr₹76.91 L
Total liabilities₹2.76 Cr₹2.33 Cr₹3.40 Cr₹2.50 Cr
Current assets₹2.89 Cr₹2.07 Cr₹2.81 Cr₹1.80 Cr
Cash & equivalents₹1.12 Cr₹41.91 L₹1.07 Cr₹45.47 L
Total assets₹5.38 Cr₹3.63 Cr₹6.33 Cr₹4.48 Cr
Employees31220237186
Gain deeper financial insights of this entity

Audited financials & ratios for Bombay Pharma Equipments.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹4.71 Cr+26.6%-1.6%+0.5%
Profit after Tax₹57.60 L+30.4%+8.8%+14.7%
Net Worth₹2.62 Cr+14.8%+3.5%+0.6%
Employees312+27.7%+16.5%+19.0%
Gain deeper financial insights of this entity

Audited financials & ratios for Bombay Pharma Equipments.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹4.71 Cr₹57.60 L+12.24%+14.06%+22.02%+10.71%0.29₹1.51 L
FY2023-24₹3.91 Cr₹43.47 L+11.12%+30.60%+33.57%+11.98%0.77₹19.55 L
FY2022-23₹3.75 Cr₹54.02 L+14.41%+12.41%+18.46%+8.54%0.50₹1.58 L
FY2021-22₹3.78 Cr₹45.14 L+11.94%+31.06%+22.89%+10.09%0.27₹2.03 L
Gain deeper financial insights of this entity

Audited financials & ratios for Bombay Pharma Equipments.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters42,60,04,07456.03%
Institutional Investors141,27,2488.89%
Public & Others361,62,77,84835.07%
See the full shareholding pattern

Promoter, institutional & public holding for Bombay Pharma Equipments.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

675 peersSame sector (Medical & Precision) — nationwide
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P1

Top 10 in Medical & Precision

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Jlnphenix Energy
Uttar Pradesh · Inc 2008
Paid-up
Revenue
C · 63
05
Paid-up
Revenue
C · 63
06
Nirav Biosolutions
PN · Inc 2011
Paid-up
Revenue
C · 63
07
Insightra Medical Private Limited
Maharashtra · Inc 2005
Paid-up
Revenue
C · 63
08
Plenum Tech
Maharashtra · Inc 2000
Paid-up
Revenue
C · 63
09
Medived
Karnataka · Inc 2006
Paid-up
Revenue
C · 63
10
Goenka Jewellers
West Bengal · Inc 1990
Paid-up
Revenue
C · 63

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Bombay Pharma Equipments

When was Bombay Pharma Equipments incorporated?
Bombay Pharma Equipments was incorporated in 1927. Its CIN is U33110MH2008PTC189053 and it is registered with the relevant Registrar of Companies.
Where is Bombay Pharma Equipments located?
Bombay Pharma Equipments is headquartered in Maharashtra.
What sector does Bombay Pharma Equipments operate in?
Bombay Pharma Equipments operates in the Medical & Precision sector (NIC code 33110), classified as Indian Non-Govt Company.
Who are the directors of Bombay Pharma Equipments?
Director details for Bombay Pharma Equipments have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Bombay Pharma Equipments?
Bombay Pharma Equipments has authorized capital of — and paid-up capital of —.
Does Bombay Pharma Equipments have any open charges?
Bombay Pharma Equipments has no open MCA-registered charges on record.
What is Bombay Pharma Equipments's Compliance Health Score?
RegisterKaro's Compliance Health Score for Bombay Pharma Equipments is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.